Flag of Nigeria

Nigeria

Destination photograph: Nigeria
Nigeria banner Eyo Festival in Lagos.jpg · Slashme · CC BY-SA 3.0, via Wikimedia Commons. Displayed at a reduced size; no image edits.

Nigeria travel health

Sources checked

Overview

Prepare for routine vaccinations, mandatory entry screening, strong malaria exposure and seasonal risks (meningitis, Lassa fever). Carry proof of vaccination when required, plan insect‑bite prevention and antimalarial prophylaxis, and expect variable access to advanced care outside major cities.

Administrative and screening requirements

Nigeria requires all international arrivals to complete the NCDC digital Health Declaration before boarding and to present the resulting QR/pdf to Port Health on arrival — airlines check completion at check‑in. Nigeria Centre for Disease Control — NCDC Health Declaration Portal.

Vaccinations and entry requirements

Separate legal/documentary requirements from clinical recommendations. The items below describe official certificate rules and common travel‑clinic advice for visitors.

Yellow fever (certificate requirement and vaccine)

Nigeria expects travellers to have a valid International Certificate of Vaccination (yellow card / e‑Yellow Card) and the NCDC declaration asks for yellow‑card details; the vaccine is recommended for personal protection for people aged ≥9 months. Get vaccinated at an approved centre at least 10 days before travel when possible; exemptions (very young infants, some immunocompromised people and older adults) are noted in national guidance. NCDC — Yellow Fever FAQs · NCDC Health Declaration Portal.

Polio (exit/reciprocal vaccination checks)

Nigeria has reported poliovirus detections in recent surveillance; some public‑health guidance and travel clinics advise that long‑stay travellers (for example ≥4 weeks) may be asked for proof of recent polio vaccination on departure and that adults with childhood series may receive a single inactivated‑polio booster before travel. Check country exit rules and carry your vaccine record. TravelHealthPro — Nigeria · CDC — Nigeria travel guidance (polio).

Routine and commonly recommended vaccines

Stay up to date with routine immunizations (MMR, DTaP/Tdap, polio, varicella, influenza). Additional routinely recommended vaccines for most travellers include hepatitis A and typhoid; hepatitis B is recommended for those with anticipated blood/sexual exposure, long stays or medical procedures. Rabies pre‑exposure vaccine should be considered for long stays, children, or travellers with occupational or remote‑area exposure to animals. Meningococcal ACWY vaccine is recommended for travel to states within the African meningitis belt during the dry season (roughly December–June). For details and age/contraindication notes, consult a travel‑health clinician. CDC — Vaccines and medicines for Nigeria · TravelHealthPro — Nigeria.

Cholera and other vaccine options

Active cholera transmission has been reported in Nigeria; oral cholera vaccine may be considered for people whose accommodation, work or itinerary places them at higher risk (humanitarian workers, those visiting outbreak areas with limited water/sanitation). Discuss cholera vaccine if you fit these categories. CDC — cholera in Nigeria.

Other health risks and practical prevention

Most visitors will benefit from planning to avoid mosquito bites, food‑ and waterborne illness, animal exposures and seasonally patterned infections. Consider daily realities of your itinerary (urban vs rural, duration, accommodation, contact with local communities) when choosing vaccines and medicines.

Malaria

Malaria transmission (primarily Plasmodium falciparum) occurs year‑round across Nigeria. CDC recommends that all travellers take prescription antimalarial prophylaxis and use insect‑bite prevention (sleeping under treated nets, repellents, clothing). Common options include atovaquone‑proguanil, doxycycline, mefloquine or tafenoquine — choice depends on medical history and destination. Start drugs as directed before travel and continue after return; consult your clinician for a regimen. CDC — Malaria guidance for Nigeria · WHO/AFRO — malaria context in Nigeria.

Lassa fever and viral hemorrhagic fevers

Lassa fever is endemic in Nigeria and shows seasonal rises; it is spread primarily from rodents and by contact with infected body fluids. Avoid contact with rodents, practice good food storage and hygiene, and seek prompt care for febrile illness. NCDC publishes regular Lassa situation reports and clinical guidance for healthcare workers. NCDC — Lassa fever sitreps and guidance · CDC — Lassa fever prevention notes.

Meningitis

Northern Nigeria lies within the African meningitis belt; risk increases in the dry season (roughly December–June). Meningococcal ACWY vaccine is advised for travellers to affected states during the dry season or for those with prolonged local exposure. Follow local advisories and seek urgent care for signs of severe headache, fever, neck stiffness or altered mental state. NCDC — public health advisory on cerebrospinal meningitis (CSM) · CDC — meningococcal guidance.

Food‑ and water‑borne infections, diarrhoea and cholera

Traveler's diarrhea is common; practise food and water hygiene, handwashing and pack oral rehydration salts. Cholera is reported regionally — avoid unsafe water and raw street foods, and consider cholera vaccine if your itinerary exposes you to outbreak conditions with limited access to safe water. CDC — food, water and cholera advice.

Animal bites, rabies and other zoonoses

Dog rabies occurs in Nigeria and wildlife reservoirs exist. If you will be in contact with animals, in remote areas, or with children, consider rabies pre‑exposure vaccination; post‑exposure prophylaxis (vaccine and immunoglobulin) may be scarce outside larger urban centres. Always wash bites immediately and seek medical care. CDC — rabies risk and guidance.

Other mosquito‑borne infections (dengue, chikungunya, Zika)

Dengue and chikungunya occur in Nigeria; avoid daytime and evening mosquito bites. For long‑stay travellers or those with occupational exposure, discuss chikungunya vaccine options where relevant. Pregnant travellers should consult a clinician about Zika risk. CDC — dengue, chikungunya, Zika notes.

Current health alerts

Only currently supported, country‑specific public‑health developments are listed below.

Imported Ebola disease — Federal Capital Territory (October 2026)

On 20 October 2026 Nigerian authorities confirmed an imported case of Ebola (Bundibugyo virus) in the Federal Capital Territory; the patient was isolated and response measures (surveillance, contact tracing, IPC) were activated. Follow NCDC updates and avoid contact with body fluids of anyone suspected to be ill. NCDC — Update on Nigeria’s Ebola disease response (25 Oct 2026) · NCDC — Situation report (case confirmation).

Lassa fever — ongoing seasonal activity (2026)

NCDC publishes weekly Lassa fever situation reports documenting confirmed cases and deaths during the 2026 peak season; travellers in affected states should avoid rodent exposure and seek care for febrile illness. NCDC — Lassa fever situation reports.

Meningitis — dry‑season risk in northern states

NCDC issued a public health advisory in March 2026 reminding the public that cerebrospinal meningitis risk rises in the dry season (roughly December–April) especially in states within the meningitis belt; travellers to northern states during the dry season should consider meningococcal vaccination where indicated. NCDC — Public Health Advisory on Cerebrospinal Meningitis (3 Mar 2026) · CDC — meningococcal guidance.

Cholera — active transmission reported

CDC reporting indicates active cholera transmission in Nigeria; travellers should follow strict water and food precautions and consider cholera vaccine if their itinerary places them in outbreak areas with limited access to safe water. CDC — cholera and waterborne disease note.

Before you travel

See a travel‑health clinician 4–6 weeks before departure to review your itinerary, health history and required paperwork. Pack insect repellent, an effective antimalarial, a first‑aid kit, oral rehydration salts and copies of vaccination records. Expect immigration and port‑health checks for the NCDC Health Declaration and your yellow‑fever documentation.

Further reading and official sources

For official entry procedures and health declarations use the NCDC Health Declaration Portal and the NCDC yellow fever guidance; for clinical vaccine and prophylaxis recommendations consult CDC travel guidance and TravelHealthPro. NCDC Health Declaration Portal · NCDC — Yellow Fever FAQs · CDC — Nigeria travel health · TravelHealthPro — Nigeria.

This information summarizes published public‑health guidance. A travel‑health professional can advise on your itinerary, medical history and vaccination needs.

AI-generated landscape illustration inspired by Nigeria
AI-generated illustration inspired by Nigeria.

Nigeria: recent disease outbreaks

Sources checked

Recent reports

Ebola (Bundibugyo virus) — imported case, Federal Capital Territory (Abuja)

On 20 October 2026 Nigeria confirmed a laboratory‑positive imported case of Ebola disease caused by the Bundibugyo virus in the Federal Capital Territory (Abuja); the patient had recent travel from Uganda, is in isolation and public health authorities have activated an incident management system and started contact tracing. NCDC update and WHO Disease Outbreak News (23 Oct 2026). WHO and national authorities report this as an imported case (investigations continue) and advise heightened surveillance; WHO does not recommend travel or trade restrictions. WHO advice. National guidance issued earlier in 2026 described enhanced passenger health‑declaration and screening measures at ports of entry; public health authorities have emphasised screening, contact monitoring and isolation rather than blanket travel bans. Federal Ministry statement (June 2026) and CDC interim traveler-management guidance.

Cholera — large outbreak concentrated in Borno State (ongoing since May 2026)

A widespread cholera outbreak that began in May 2026 has continued through September–October, with transmission concentrated in north‑east Nigeria. WHO reporting shows Nigeria accounted for the largest share of cholera cases in the African Region through 30 August 2026 (69,263 cases, 439 deaths year‑to‑date) and reported 10,807 new cases in August 2026; Borno State has been the principal hotspot. WHO WER (data to 30 Aug 2026) and WHO African Region feature reporting Borno totals (as of end‑September) and response activities. WHO AFRO (7 Oct 2026). The Nigeria Centre for Disease Control (NCDC) and partners are coordinating case management, WASH and surveillance in affected states; travellers should be aware that cholera risk is higher where safe water and sanitation are limited. NCDC weekly report (Aug 2026).

Diphtheria — sustained transmission in multiple northern and central states

Nigeria has reported a large, ongoing diphtheria upsurge in 2026 with thousands of suspected and confirmed cases and several hundred deaths reported year‑to‑date; NCDC situational reporting and state health briefings indicate that eight states account for most confirmed cases (including Kano, Borno and Plateau). NCDC diphtheria situation report and national media reporting summarise numbers and state‑level impact. Channels TV (5 Sep 2026). Diphtheria is vaccine‑preventable; NCDC and partners are emphasising case detection, treatment, infection prevention and targeted immunization efforts in affected areas (follow local public‑health instructions if you are travelling with children). NCDC situation materials.

Lassa fever — seasonal transmission with increased case‑fatality noted in 2026

Lassa fever activity has continued through the 2026 dry‑season season. NCDC Week‑40 reporting (epi week 28 Sept–4 Oct 2026) documents 1,138 confirmed cases and 268 deaths in 2026 (24 states, 119 LGAs) with most confirmed infections reported from Ondo, Bauchi, Taraba, Edo and Benue states; the report notes a higher case fatality ratio than the same period in 2025. These are locally acquired human cases (rodent‑borne and person‑to‑person transmission are pathways). NCDC Lassa fever sitrep (Epi week 40, 2026) and contemporary press coverage. NCDC recommends strengthened rodent control, early detection and IPC in health facilities; travellers to endemic areas should minimise rodent exposure and follow food/storage hygiene per public‑health guidance. NCDC Lassa advisories (Mar 2026) and TravelHealthPro (traveler precautions).

These entries summarise verified reports and situation updates available as of 27 October 2026. Conditions can change quickly; travellers should check national sources (NCDC), WHO updates and their own government travel‑health advice for current information and follow local public‑health instructions before and during travel.